American International Group, Inc. 13D and 13G filings for BridgeBio Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:51 pm Purchase |
2021-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
AMERICAN INTERNATIONAL GROUP INC AIG |
2,529,272 9.000% |
281,306 (+12.51%) |
Filing |
| 2021-02-16 3:19 pm Purchase |
2020-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
AMERICAN INTERNATIONAL GROUP INC AIG |
2,247,966 9.100% |
2,247,966 (New Position) |
Filing |
| 2021-02-12 7:33 pm Sale |
2020-12-31 | 13G | BridgeBio Pharma, Inc. BBIO |
AMERICAN INTERNATIONAL GROUP INC AIG |
3,381,412 2.800% |
-3,383,180 (-50.01%) |
Filing |